- Previous Article
- Next Article
- Table of Contents
Biochemical and Biophysical Research Communications, Vol.362, No.4, 785-788, 2007
Corticotropin-releasing factor family and its receptors: Tumor therapeutic targets?
Urocortin (UCN) and corticotropin-releasing factor (CRF) are members of CRF family. Though CRF is mainly distributed in central nervous system (CNS), UCN has been reported to play biologically diverse roles in several systems such as cardiovascular, respiratory, digestive, reproductive, stress, immunologic system, etc. UCN and CRF bind to two known receptors, CRFR1 and CRFR2, to function. Both CRF receptors are distributed in CNS and periphery tissues, and their expression in cancer tissues has been reported. Now there are many documents indicating UCN/CRF play an important role in the regulation of carcinogenesis. There is also evidence indicating UCN/CRF have anticancer effects via CRFRs. This paper will review the effects of CRF family in cancers. (c) 2007 Elsevier Inc. All rights reserved.
Keywords:urocortin;corticotropin-releasing factor;corticotropin-releasing factor receptor;tumor angiogenesis;tumor chemotherapy